IP Library › Granted Patent US 8,366,644
Granted Patent B2
US 8,366,644 · App. 12/403,911 · Granted Feb 5, 2013

System and method for reduced pressure charging

Inventors: Chris Coward (Wareham, GB); Keith Patrick Heaton (Poole, GB)
Assignee: KCI Licensing, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,366,644
App. No.
12/403,911
Granted
Feb 5, 2013
Kind
B2
Abstract

A reduced pressure treatment system includes a compressible chamber positionable beneath a foot of a user and being movable between an expanded position and a compressed position. The compressible chamber includes an inlet and an outlet. An inlet valve is in fluid communication with the inlet to prevent fluid within the compressible chamber from exiting the inlet, and an outlet valve is in fluid communication with the outlet to prevent fluid from entering the compressible chamber through the outlet. A biasing member is disposed within the compressible chamber to bias the compressible chamber toward the expanded position, and a manifold is positionable at a tissue site and in fluid communication with the inlet of the compressible chamber.

Claims (77)

1. A reduced pressure treatment system comprising:

a compressible bladder positioned beneath a foot of a user, the compressible bladder having a chamber substantially enclosed by a chamber wall, the compressible bladder being movable between an expanded position and a compressed position to generate a reduced pressure;

a resilient member operatively associated with the chamber wall to bias the compressible bladder toward the expanded position;

a manifold positioned at a tissue site of the user and in fluid communication with the chamber of the compressible bladder; and

a pressure regulator fluidly connected between the chamber and the manifold to regulate the reduced pressure delivered to the tissue site.

2. The system of claim 1 , further comprising:

a canister fluidly connected between the chamber and the manifold to collect exudate from the tissue site.

3. The system of claim 1 , wherein the compressible bladder generates the reduced pressure within the chamber as the compressible bladder expands toward the expanded position.

4. The system of claim 1 , wherein the biasing member is disposed within the chamber.

5. The system of claim 1 , wherein the biasing member is an open-cell foam.

6. The system of claim 1 , wherein the biasing member is disposed outside of the chamber.

7. The system of claim 1 , further comprising:

a second compressible bladder positioned beneath the foot of the user, the second compressible bladder having a second chamber substantially enclosed by a second chamber wall, the second compressible bladder being movable between an expanded position and a compressed position to generate a second reduced pressure;

a second biasing member operatively associated with the second chamber wall to bias the second compressible bladder toward the expanded position;

wherein the second chamber of the second compressible bladder is in fluid communication with the manifold; and

wherein the first compressible bladder is positioned beneath a forefoot region of the foot and the second compressible bladder is positioned beneath a heel region of the foot.

8. A reduced pressure treatment system comprising:

a compressible chamber positionable beneath a foot of a user and being movable between an expanded position and a compressed position, the compressible chamber having an inlet and an outlet;

an inlet valve in fluid communication with the inlet to prevent fluid within the compressible chamber from exiting the inlet;

an outlet valve in fluid communication with the outlet to prevent fluid from entering the compressible chamber through the outlet;

a biasing member disposed within the compressible chamber to bias the compressible chamber toward the expanded position;

a manifold positionable at a tissue site and in fluid communication with the inlet of the compressible chamber; and

a pressure regulator fluidly connected between the inlet of the compressible chamber and the manifold to regulate a reduced pressure delivered to the tissue site.

9. The system of claim 8 , further comprising:

a canister fluidly connected between the inlet of the compressible chamber and the manifold to collect exudate from the tissue site.

10. The system of claim 8 , wherein the compressible chamber is a bladder.

11. The system of claim 8 , wherein the compressible chamber generates the reduced pressure as the compressible chamber expands toward the expanded position.

12. The system claim 8 , wherein the biasing member is an open-cell foam.

13. The system of claim 8 , further comprising:

a second compressible chamber positionable beneath the foot of the user and being movable between an expanded position and a compressed position, the second compressible chamber having a second inlet and a second outlet;

a second inlet valve in fluid communication with the second inlet to prevent fluid within the second compressible chamber from exiting the second inlet;

a second outlet valve in fluid communication with the second outlet to prevent fluid from entering the second compressible chamber through the second outlet;

a second biasing member disposed within the second compressible chamber to bias the second compressible chamber toward the expanded position;

wherein the second compressible chamber is in fluid communication with the manifold; and

wherein the first compressible chamber is positioned beneath a forefoot region of the foot and the second compressible chamber is positioned beneath a heel region of the foot.

14. A reduced pressure treatment system comprising:

a compressible bladder positionable beneath a foot of a user, the compressible bladder having a chamber and being movable between an expanded position and a compressed position,

a biasing member disposed within the chamber to bias the compressible bladder toward the expanded position;

a pressure regulator having a first variable-volume cavity and a second variable-volume cavity, the first variable-volume cavity being fluidly connected to the chamber of the compressible bladder; and

a manifold positionable at a tissue site and in fluid communication with the second variable-volume cavity of the pressure regulator.

15. The system of claim 14 , wherein the first variable-volume cavity is configured to expand as the first variable-volume cavity receives positively pressured air from the chamber.

16. The system of claim 14 , wherein the second variable-volume cavity is configured to expand and generate a reduced pressure as the first variable-volume cavity expands.

17. The system of claim 14 , wherein:

the first variable-volume cavity is configured to expand as the first variable-volume cavity receives positively pressured air from the chamber; and

the second variable-volume cavity is configured to expand and generate a reduced pressure as the first variable-volume cavity expands.

18. The system of claim 14 , wherein the pressure regulator includes a bellows device.

19. The system of claim 14 , wherein the chamber includes an inlet and an outlet and the system further comprises:

an inlet valve in fluid communication with the inlet to prevent fluid exiting the chamber from passing through the inlet; and

an outlet valve in fluid communication with the outlet to prevent fluid from entering the chamber through the outlet.

20. The system of claim 14 , further comprising:

a canister fluidly connected between the second variable-volume cavity and the manifold to collect exudate from the tissue site.

21. The system claim 14 , wherein the biasing member is an open-cell foam.

22. The system of claim 14 , further comprising:

a second compressible bladder positionable beneath the foot of the user, the second compressible bladder having a second chamber and being movable between an expanded position and a compressed position;

a second biasing member disposed within the second chamber to bias the second compressible bladder toward the expanded position;

wherein the second chamber of the second compressible bladder is in fluid communication with the first variable-volume cavity; and

wherein the first compressible bladder is positioned beneath a forefoot region of the foot and the second compressible bladder is positioned beneath a heel region of the foot.

23. A reduced pressure treatment system comprising:

a compressible bladder positioned beneath a foot of a user, the compressible bladder having a chamber substantially enclosed by a chamber wall, the compressible bladder being movable between an expanded position and a compressed position to generate a reduced pressure;

a resilient member operatively associated with the chamber wall to bias the compressible bladder toward the expanded position;

a manifold positioned at a tissue site of the user and in fluid communication with the chamber of the compressible bladder; and

a second compressible bladder positioned beneath the foot of the user, the second compressible bladder having a second chamber substantially enclosed by a second camber wall, the second compressible bladder being movable between an expanded position and a compressed position to generate a second reduced pressure;

a second biasing member operatively associated with the second chamber wall to bias the second compressible bladder toward the expanded position;

wherein the second chamber of the second compressible bladder is in fluid communication with the manifold; and

wherein the first compressible bladder is positioned beneath a forefoot region of the foot and the second compressible bladder is positioned beneath a heel region of the foot.

24. A reduced pressure treatment system comprising:

a compressible chamber positionable beneath a foot of a user and being movable between an expanded position and a compressed position, the compressible chamber having an inlet and an outlet;

an inlet valve in fluid communication with the inlet to prevent fluid within the compressible chamber from exiting the inlet;

an outlet valve in fluid communication with the outlet to prevent fluid from entering the compressible chamber through the outlet;

a biasing member disposed within the compressible chamber to bias the compressible chamber toward the expanded position;

a manifold positionable at a tissue site and in fluid communication with the inlet of the compressible chamber; and

a second compressible chamber positionable beneath the foot of the user and being movable between an expanded position and a compressed position, the second compressible chamber having a second inlet and a second outlet;

a second inlet valve in fluid communication with the second inlet to prevent fluid within the second compressible chamber from exiting the second inlet;

a second outlet valve in fluid communication with the second outlet to prevent fluid from entering the second compressible chamber through the second outlet;

a second biasing member disposed within the second compressible chamber to bias the second compressible chamber toward the expanded position;

wherein the second compressible chamber is in fluid communication with the manifold; and

wherein the first compressible chamber is positioned beneath a forefoot region of the foot and the second compressible chamber is positioned beneath a heel region of the foot.

Assignments (5)
RELEASE OF SECURITY INTEREST IN PATENTS Recorded Nov 7, 2019
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: KCI USA, INC.; KCI LICENSING, INC.
Reel/Frame 050966/0547 →
RELEASE OF SECURITY INTEREST REEL/FRAME 040098/0268 Recorded Feb 8, 2017
From: WILMINGTON TRUST
To: KCI USA, INC.
Reel/Frame 041666/0320 →
LIMITED THIRD LIEN INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Oct 7, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040291/0237 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 21, 2016
From: KCI USA, INC.; LIFECELL CORPORATION; KCI LICENSING, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 040098/0268 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2009
From: COWARD, CHRISTOPHER GUY; HEATON, KEITH PATRICK
To: KCI LICENSING, INC.
Reel/Frame 022873/0777 →
Continuity (2)
Provisional Application 61036391 · Mar 13, 2008
Related Publication 20090234260A1 · Sep 17, 2009